Information:
Fel:
ID
23464
Beskrivning
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing; ODM derived from: https://clinicaltrials.gov/show/NCT00484640
Länk
https://clinicaltrials.gov/show/NCT00484640
Nyckelord
Versioner (1)
- 2017-07-05 2017-07-05 -
Uppladdad den
5 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Atrial Fibrillation NCT00484640
Eligibility Atrial Fibrillation NCT00484640
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT00484640
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Caucasian | Hispanic white | Age
Item
caucasian male and female patients(including hispanic white) greater than or equal to 40 years of age;
boolean
C0043157 (UMLS CUI [1])
C1533020 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C1533020 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Coumadin Started | Coumadin Dosage Stable Absent
Item
patients initiating coumadin therapy without a documented history of stabilized dose of coumadin therapy;
boolean
C0699129 (UMLS CUI [1,1])
C1272689 (UMLS CUI [1,2])
C0699129 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
C1272689 (UMLS CUI [1,2])
C0699129 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
Target INR
Item
target inr of 2 to 3.5;
boolean
C1521840 (UMLS CUI [1,1])
C0525032 (UMLS CUI [1,2])
C0525032 (UMLS CUI [1,2])
Childbearing Potential Contraceptive methods | Female Condoms | Oral contraception | Intrauterine Devices | Sexual Abstinence
Item
women of childbearing potential must use an effective method of birth control(e.g. condom,oral contraceptives, indwelling intrauterine device, abstinence.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0221829 (UMLS CUI [2])
C0029151 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
C0700589 (UMLS CUI [1,2])
C0221829 (UMLS CUI [2])
C0029151 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
Age
Item
age less than 40 years;
boolean
C0001779 (UMLS CUI [1])
Native Americans | Asians | African
Item
patients of known native american, asian, or african descent;
boolean
C0282204 (UMLS CUI [1])
C0078988 (UMLS CUI [2])
C0027567 (UMLS CUI [3])
C0078988 (UMLS CUI [2])
C0027567 (UMLS CUI [3])
Thrombocytopenia | Platelet Count measurement
Item
patients with thrombocytopenia(platelet count<50x10 cells/ml);
boolean
C0040034 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0032181 (UMLS CUI [2])
Coumadin Dosage
Item
patient has previously received coumadin and information on dosing of the patient is known at time of restarting coumadin;
boolean
C0699129 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
Hepatic Insufficiency Severe | Hepatic Insufficiency Moderate | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
patients with severe to moderate hepatic insufficiency (ast or alt less than 2x the upper limit of normal;
boolean
C1306571 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C1306571 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0205082 (UMLS CUI [1,2])
C1306571 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
Medical contraindication Coumadin
Item
clinical contraindication for coumadin therapy;
boolean
C1301624 (UMLS CUI [1,1])
C0699129 (UMLS CUI [1,2])
C0699129 (UMLS CUI [1,2])
Gender Pregnancy test positive | Breast Feeding
Item
female patients with a positive pregnancy test or women who are breastfeeding
boolean
C0079399 (UMLS CUI [1,1])
C0240802 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0240802 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])